BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 802071)

  • 1. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):91-3. PubMed ID: 786690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
    Glazer N
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):561-72. PubMed ID: 4628678
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
    Lang E; Fitscha P; Schiess W
    Wien Med Wochenschr; 1979 Sep; 129(17):484-8. PubMed ID: 120078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combination therapy with alprenolol and hydralazine in essential hypertension. A controlled clinical study].
    Pape J
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1139-42. PubMed ID: 4584539
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arterial hypertension with the combination of hydralazine and propranolol].
    Sabbaga E; Chocair PR; Ianhez LE; Massola VC
    Rev Paul Med; 1974 Mar; 83(3):97-100. PubMed ID: 4445689
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L; Jänne J; Keyriläinen O; Koskinen P; Leskinen O; Pitkäjärvi T; Reinikainen M
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combined treatment with beta-receptor blocker pindolol and diureticum trichlormethiazidum in patients with essential hypertony in stadium II WHO (author's transl))].
    Zdichynec B
    Z Kardiol; 1977 Sep; 66(9):508-10. PubMed ID: 335687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatemtn of arterial hypertension with the combination of hydralazine and propranolol].
    Sabbaga E; Chocair PR; Ianhez LE; Massola VC
    Rev Paul Med; 1974 Mar; 83(3):97-100. PubMed ID: 4445688
    [No Abstract]   [Full Text] [Related]  

  • 16. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 17. Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Sievert A; Aurell M; Hansson L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S102-4. PubMed ID: 2455104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).
    Persson I
    Eur J Clin Pharmacol; 1977 Jul; 11(6):419-21. PubMed ID: 330169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension during pregnancy with hydralazine monotherapy or with combined therapy with hydralazine and pindolol.
    Rosenfeld J; Bott-Kanner G; Boner G; Nissenkorn A; Friedman S; Ovadia J; Merlob P; Reisner S; Paran E; Zmora E
    Eur J Obstet Gynecol Reprod Biol; 1986 Aug; 22(4):197-204. PubMed ID: 3743860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.